fluorexon has been researched along with Leukemia, Myeloid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herman, PR; Li, J; Lilge, L; Munce, NR | 1 |
| Legrand, O; Marie, JP; Perrot, JY; Simonin, G; Zittoun, R | 1 |
| Holló, Z; Homolya, L; Jakab, K; Kappelmayer, J; Karászi , E; Kiss, A; Nahajevszky, S; Rejtô, L; Sarkadi, B; Szakács, G; Telek, B | 1 |
3 other study(ies) available for fluorexon and Leukemia, Myeloid
| Article | Year |
|---|---|
Microfabricated system for parallel single-cell capillary electrophoresis.
Topics: Comet Assay; Electrophoresis, Capillary; Electrophoresis, Microchip; Fluoresceins; Fluorescent Dyes; Humans; Leukemia, Myeloid; Tumor Cells, Cultured | 2004 |
Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients.
Topics: Acute Disease; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Drug Resistance, Multiple; Flow Cytometry; Fluoresceins; Humans; Leukemia, Myeloid; Multidrug Resistance-Associated Proteins; Prognosis; Tumor Cells, Cultured | 1998 |
Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia.
Topics: Acute Disease; Bone Marrow Cells; Cells, Cultured; Drug Resistance, Multiple; Female; Fluoresceins; Fluorescent Dyes; Follow-Up Studies; Humans; Leukemia, Myeloid; Leukocytes; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Prognosis; Regression Analysis | 2001 |